SPDL1 and non-small cell lung carcinoma: Zhao et al. evaluated the sPD-L1 levels during thoracic radiotherapy in inoperable, locally advanced NSCLC patients, and observed significant longer OS in patients with low baseline sPD-L1 levels29.